Tickerplace logo

Tickerplace

Marker Therapeutics, Inc. logo

MRKRMarker Therapeutics, Inc.

MRKR Stock Price, Valuation & Chart | Marker Therapeutics, Inc.

Compare
$1.250-0.05 (-3.85%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyMRKR intrinsic valueMRKR calculated fair value vs price
OverviewFinancialsDividendsRatios

MRKR Historical price chart

MRKR Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization20.84M
PE Ratio-2.66
EPS-0.47
Trading Volume167.58K
Today's High/Low1.3/1.24
Dividend Yield0.00
52 Week High/Low2.46/0.83
Shares Outstanding16.67M
MRKR Financial Statement
MRKR Analyst ratings
MRKR Analysis & performance metrics

MRKR Company profile

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and…

MRKR Management team

Management
F. Andrew Dorr M.D.
Chief Medical Officer
Juan F. Vera M.D.CEO
Co-Founder, Chief Executive Officer, President, Treasurer, Secretary & Director
Maria-Bernadette Madel Ph.D.CTO
Director of Corporate Operations & External Communications
Robert Z. Florkiewicz Sr., Ph.D.CTO
Senior Director of Molecular Biology & Virology
Edmund Cheung
Vice President of Human Resources
Patricia Allison
Head of Clinical Operations
Elizabeth DonnellyCTO
Director of Administration
Mary Newman Ph.D.
Head of Regulatory Affairs
Total 8 executives

MRKR Frequently asked questions

What is Marker Therapeutics, Inc. (MRKR) Stock Price?

Current stock price of Marker Therapeutics, Inc. (MRKR) stock is $1.250. The stock price is -3.85% lower in the session. The intraday range can be seen from this page. Volume of Marker Therapeutics, Inc. (MRKR) stock is 167.58K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Marker Therapeutics, Inc. (MRKR) stock price going up or down today?

The stock price of Marker Therapeutics, Inc. (MRKR) can change with earnings, company news, and overall market sentiment. Marker Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Marker Therapeutics, Inc. stock expensive at its current price?

Whether Marker Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MRKR on this page is -2.66. EPS on this page is -0.47. Compare those figures with peers and growth expectations before deciding if the current Marker Therapeutics, Inc. price is justified.

How has the stock price of Marker Therapeutics, Inc. (MRKR) performed historically?

Historical performance for Marker Therapeutics, Inc. (MRKR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MRKR reacted to past earnings and market events.

Should I buy Marker Therapeutics, Inc. (MRKR) stock, at this price?

Buying Marker Therapeutics, Inc. (MRKR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.